دورية أكاديمية
347MO 5-Aminolevulinic acid sonodynamic therapy in recurrent glioblastoma: A first-in-human phase 0/1 clinical trial.
| العنوان: | 347MO 5-Aminolevulinic acid sonodynamic therapy in recurrent glioblastoma: A first-in-human phase 0/1 clinical trial. |
|---|---|
| المؤلفون: | Sanai, N.1 (AUTHOR), Tien, A-C.1 (AUTHOR), Tovmasyan, A.1 (AUTHOR), Chang, Y-W.1 (AUTHOR), Margaryan, T.1 (AUTHOR), Hendrickson, K.1 (AUTHOR), Eschbacher, J.1 (AUTHOR), Yoo, W.1 (AUTHOR), Harmon, J.1 (AUTHOR), Quarles, C.1 (AUTHOR), Alhilali, L.1 (AUTHOR), Barani, I.1 (AUTHOR), Mehta, S.N.1 (AUTHOR), Mirzadeh, Z.1 (AUTHOR) |
| المصدر: | Annals of Oncology. 2021 Supplement 5, Vol. 32, pS518-S519. 2p. |
| مصطلحات موضوعية: | *GLIOBLASTOMA multiforme, *CLINICAL trials, *ACIDS |
| قاعدة البيانات: | Academic Search Index |
Full Text Finder | تدمد: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2021.08.011 |